New Discoveries in the Immunobiology of Asthma: Implications for Therapy (D1)
New Discoveries in the Immunobiology of Asthma: Implications for Therapy (D1) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Apr 02 - 06, 2020 at Snowbird Resort, Snowbird, Utah, United States of America.
The goals of this conference, distinct from the previous ones in 2013 and 2017, are to highlight the most recent basic-science breakthroughs in the pathogenesis of asthma and related inflammatory airway diseases, and to place these discoveries in the context of new therapeutics and therapeutic directions for this type of disease. The organizers are particularly intent on highlighting immunological and interrelated non-immunological approaches to identify, validate, and translate new biological targets into new therapeutics.
The topic is timely and urgent given the recent mechanistic insights into inflammatory airway disease and the current maturation of new biological therapies for asthma that are now just entering clinical application. Indeed, the recent successes and in some cases unforeseen failures of clinical trials of anti-asthma therapeutics highlights the importance of convening a broad-based high-level scientific conference to highlight and focus the discovery and development of new therapeutics for asthma and related chronic lower respiratory disease, now the third most common cause of death in the U.S and the fifth most common worldwide.
Additional details will be posted as soon as they are available.
|Contact No. :||+1 800-253-0685
January 07, 2020
|Registration Type||Last Date||Price|
|Non-Student Registration Late and Onsite Fee||02 Apr,2020||USD 1045.00|
|Student Registration Late and Onsite Fee||02 Apr,2020||USD 820.00|
|Registration Type||End Date||Price|
|Non-Student Registration Early Fee||03 Feb,2020||USD 845.00|
|Student Registration Early Fee||03 Feb,2020||USD 620.00|